トップインタビュー キューピー代表取締役社長 鈴木豊氏--「決まり通り」を疑わせ自ら考え、動く社員を育成

The pharmacokinetics of a fixed dose of midazolam (0.3 mg kg-1 i.v.) were studied in detail in 115 healthy patients or volunteers and nine were found with a prolonged elimination half-life. A further 102 patients had an abbreviated pharmacokinetic study, of whom five showed a similar abnormality. De... View More